My investment thesis from the get go was very clear...... investing in a specy Bio with a lot of potential willing to writeoff my investment if turned sour........... Now wen i invested it was a spec bio with a lot of potential with a great financial health conducting trials second to none chairman and CEO were constantly enticing share holders with a truck load of goodies in term of financial options they had. If that was true y are they leaving it till the sp dropped from 15c to 3c........ where is the financial prudence of a million dollar CEO???????
As a trial clinician LC as good as you can ever get with a wealth of experience and it clearly shows its no joke to manage so many trials across the platforms but in doing so please dont forget your main hat is that of a CEO for which you a taking big bucks fo for F sake do 10% justice to the role of a ceo.
As a CEO you have to arrest the financial bleeding and manage it better and more importantly take steps well in advance to improve the financial conditions of the company........ you know with all the presentations we were boosting abt the 135 million dollar cash and so on........
My only problem and its a bloody major problem which can lead to company ceasing to exist thats having cash on books....... that was clearly mismanaged by the board there is no two ways abt it....... now b4 u jump in to say trials costs money........ exactly it does thats y u are being paid in bloody millions to manage it. Act early dont let us live pay check to pay check its disgusting....... for ppl jumping on board to give me a free advise if it pains sell it bla bla....... keep that advise to ur self...... it doesn't pain me this can be a write off for me but it feels bad for the pure potential this had and now it feels like it never wants to grow out of its wanna be pants...... bloody coming close to a decade still languishing (not in science but in mis management)
spidey
- Forums
- Charts
- IMUGENE CHART. TA only
IMU
imugene limited
Add to My Watchlist
8.33%
!
1.1¢

My investment thesis from the get go was very clear.........
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $82.13M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.1¢ | $376.2K | 32.83M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 3534042 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 11298051 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 3464042 | 0.011 |
86 | 22843240 | 0.010 |
29 | 12914663 | 0.009 |
10 | 1865122 | 0.008 |
6 | 2065714 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 11298051 | 21 |
0.013 | 12890526 | 28 |
0.014 | 8268651 | 33 |
0.015 | 8243629 | 29 |
0.016 | 6705871 | 27 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online